Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low‐to‐middle income Asian country
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Attitudes and training needs of oncologists and surgeons in mainstreaming breast cancer genetic counseling in a low‐to‐middle income Asian country
Authors
Keywords
-
Journal
Journal of Genetic Counseling
Volume -, Issue -, Pages -
Publisher
Wiley
Online
2022-04-28
DOI
10.1002/jgc4.1579
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Population-Based Study of Genes Previously Implicated in Breast Cancer
- (2021) Chunling Hu et al. NEW ENGLAND JOURNAL OF MEDICINE
- Breast Cancer Risk Genes — Association Analysis in More than 113,000 Women
- (2021) et al. NEW ENGLAND JOURNAL OF MEDICINE
- Mainstream genetic testing for breast cancer patients: early experiences from the Parkville Familial Cancer Centre
- (2021) Catherine Beard et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Mainstreamed genetic testing of breast cancer patients in two hospitals in South Eastern Norway
- (2020) Eli Marie Grindedal et al. Familial Cancer
- Utility of a mainstreamed genetic testing pathway in breast and ovarian cancer patients during the COVID-19 pandemic
- (2020) Patrick R. Benusiglio et al. European Journal of Medical Genetics
- TBCRC 048: Phase II Study of Olaparib for Metastatic Breast Cancer and Mutations in Homologous Recombination-Related Genes
- (2020) Nadine M. Tung et al. JOURNAL OF CLINICAL ONCOLOGY
- Moving into the mainstream: healthcare professionals’ views of implementing treatment focussed genetic testing in breast cancer care
- (2019) Nina Hallowell et al. Familial Cancer
- Germline Genetic Testing: What the Breast Surgeon Needs to Know
- (2019) Jennifer K. Plichta et al. ANNALS OF SURGICAL ONCOLOGY
- GeparOLA: A randomized phase II trial to assess the efficacy of paclitaxel and olaparib in comparison to paclitaxel/carboplatin followed by epirubicin/cyclophosphamide as neoadjuvant chemotherapy in patients (pts) with HER2-negative early breast cancer (BC) and homologous recombination deficiency (HRD).
- (2019) Peter A. Fasching et al. JOURNAL OF CLINICAL ONCOLOGY
- A systematic review of the international prevalence of BRCA mutation in breast cancer
- (2019) Nigel Armstrong et al. Clinical Epidemiology
- Inequities in multi-gene hereditary cancer testing: lower diagnostic yield and higher VUS rate in individuals who identify as Hispanic, African or Asian and Pacific Islander as compared to European
- (2019) Mesaki K. Ndugga-Kabuye et al. Familial Cancer
- Neoadjuvant Talazoparib for Patients With Operable Breast Cancer With a Germline BRCA Pathogenic Variant
- (2019) Jennifer K. Litton et al. JOURNAL OF CLINICAL ONCOLOGY
- Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians
- (2019) Erin W. Dekanek et al. Journal of Genetic Counseling
- Cost-effectiveness and comparative effectiveness of cancer risk management strategies in BRCA1/2 mutation carriers: a systematic review
- (2018) Lara Petelin et al. GENETICS IN MEDICINE
- Evaluation of a Streamlined Oncologist-Led BRCA Mutation Testing and Counseling Model for Patients With Ovarian Cancer
- (2018) Nicoletta Colombo et al. JOURNAL OF CLINICAL ONCOLOGY
- Germline BRCA mutation and outcome in young-onset breast cancer (POSH): a prospective cohort study
- (2018) Ellen R Copson et al. LANCET ONCOLOGY
- Talazoparib in Patients with Advanced Breast Cancer and a Germline BRCA Mutation
- (2018) Jennifer K. Litton et al. NEW ENGLAND JOURNAL OF MEDICINE
- The Global State of the Genetic Counseling Profession
- (2018) MaryAnn Abacan et al. EUROPEAN JOURNAL OF HUMAN GENETICS
- Mainstreaming cancer genetics: A model integrating germline BRCA testing into routine ovarian cancer clinics
- (2017) Maira Kentwell et al. GYNECOLOGIC ONCOLOGY
- Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer
- (2017) Allison W. Kurian et al. JOURNAL OF CLINICAL ONCOLOGY
- Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation
- (2017) Mark Robson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural Barriers to Diagnosis and Treatment of Cancer in Low- and Middle-Income Countries: The Urgent Need for Scaling Up
- (2016) Eduardo Cazap et al. JOURNAL OF CLINICAL ONCOLOGY
- Understanding of BRCA VUS genetic results by breast cancer specialists
- (2015) B. K. Eccles et al. BMC CANCER
- Non-genetic health professionals’ attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer
- (2015) Kirsten F. L. Douma et al. Familial Cancer
- Georgia Primary Care Providers’ Knowledge of Hereditary Breast and Ovarian Cancer Syndrome
- (2015) Navya Nair et al. JOURNAL OF CANCER EDUCATION
- Health professionals’ evaluation of delivering treatment-focused genetic testing to women newly diagnosed with breast cancer
- (2014) Kirsten F. L. Douma et al. Familial Cancer
- Oncology health professionals’ attitudes toward treatment-focused genetic testing for women newly diagnosed with breast cancer
- (2013) Stephanie Burcher et al. Personalized Medicine
- Essential Elements of Genetic Cancer Risk Assessment, Counseling, and Testing: Updated Recommendations of the National Society of Genetic Counselors
- (2011) Bronson D. Riley et al. Journal of Genetic Counseling
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search